Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.
Gaspar Manuel Parra-BracamonteFrancisco E Parra-BracamonteNicolas López-VillalobosAna Laura Lara-RiveraPublished in: Nephrology (Carlton, Vic.) (2020)
Chronic kidney disease (CKD) is a recognized public health problem and key determinant of poor health outcomes. In Mexico, this condition has been associated with high and significant risk of death in COVID-19 patients; however, not enough attention has been given to the vulnerable population as the increasing numbers and fatality rates suggest. This study evaluated the effect of interaction between CKD condition and other risk factors (sex, diabetes, hypertension and obesity) on the survival rate of positive patients for COVID-19 in Mexico. The results from this study support that CKD patients is a population at high risk for mortality for COVID-19 and that COVID-19 positive inpatients with CKD and diabetes are highly vulnerable to death.
Keyphrases
- chronic kidney disease
- end stage renal disease
- sars cov
- coronavirus disease
- public health
- type diabetes
- risk factors
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- cardiovascular disease
- blood pressure
- insulin resistance
- coronary artery disease
- physical activity
- glycemic control
- body mass index
- weight gain
- arterial hypertension